MYC, a well-known oncogene with broad effects involved in cell cycle and tumor metabolism (34), has been reported as a prognostic biomarker in ESCC (35) and some other cancers including breast cancer (36) and lung cancer (37, 38). Here, MYC is linked to esophageal squamous cell carcinoma.